Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer has been sued for allegedly marketing its blockbuster Lipitor brand as a drug that may prevent heart disease in women and seniors, when there is no evidence to back such a claim.
Lipitor, an anti-cholesterol therapy, generates revenue in excess of $10 billion a year for Pfizer.
“We believe Pfizer intentionally ignored the scientific evidence—and lack thereof—and launched a multi-million-dollar ad campaign designed to push the drug to anyone they could convince to buy it,” said Steve Berman, the attorney who filed the suit.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in